
Grifols, S.A. GRFS
$ 8.69
2.24%
Annual report 2024
added 04-04-2026
Grifols, S.A. EBITDA per Share 2011-2026 | GRFS
Annual EBITDA per Share Grifols, S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 0.87 | -0.04 | -0.05 | -0.01 | -0.03 | 4.29 | -0.00528 | -0.00438 | -0.000623 | -0.00071 | -0.000899 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.29 | -0.05 | 0.456 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
Burford Capital Limited
BUR
|
1.11 | $ 4.73 | 0.42 % | $ 761 M | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
4.25 | $ 333.39 | -1.77 % | $ 43.7 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-6.03 | $ 3.17 | 3.93 % | $ 5.22 M | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-1.68 | $ 3.73 | 3.04 % | $ 8.97 B | ||
|
AlloVir
ALVR
|
-3.02 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
-8.81 | $ 7.42 | -15.1 % | $ 73.3 M | ||
|
Allakos
ALLK
|
-2.19 | - | - | $ 28.6 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
-0.77 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-1.05 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
3.68 | $ 21.68 | 1.4 % | $ 1.01 B | ||
|
Cabaletta Bio
CABA
|
-1.7 | $ 3.4 | 4.29 % | $ 342 M | ||
|
CymaBay Therapeutics
CBAY
|
-0.95 | - | - | $ 3.45 B | ||
|
BioNTech SE
BNTX
|
62.6 | $ 99.47 | 1.08 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
-2.35 | - | -10.17 % | $ 12.2 K | ||
|
ContraFect Corporation
CFRX
|
-124 | - | -5.16 % | $ 5.39 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
0.1 | - | - | $ 399 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-0.66 | $ 4.24 | 2.17 % | $ 453 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-0.09 | $ 24.58 | -2.03 % | $ 3.13 B | ||
|
AIkido Pharma
AIKI
|
-3.89 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
0.38 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
-0.99 | $ 1.49 | 0.68 % | $ 397 M | ||
|
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
0.42 | - | 0.49 % | $ 251 B | ||
|
Checkpoint Therapeutics
CKPT
|
-1.42 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-2.67 | - | -16.75 % | $ 25.8 M | ||
|
Celldex Therapeutics
CLDX
|
-4.28 | $ 33.87 | 1.62 % | $ 2.25 B | ||
|
AVROBIO
AVRO
|
0.24 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
-0.4 | - | - | $ 25.3 M | ||
|
bluebird bio
BLUE
|
-1.97 | - | - | $ 546 M | ||
|
AstraZeneca PLC
AZN
|
0.74 | - | - | $ 96.9 B | ||
|
Akero Therapeutics
AKRO
|
-4.25 | - | - | $ 3.67 B |